-
1
-
-
0015043830
-
L-dopa therapy of Parkinson's disease: Plasma L-dopa concentration, therapeutic response, and side effects
-
Muenter MD, Tyce GM. L-dopa therapy of Parkinson's disease: Plasma L-dopa concentration, therapeutic response, and side effects. Mayo Clin Proc 1971;46:231-239.
-
(1971)
Mayo Clin Proc
, vol.46
, pp. 231-239
-
-
Muenter, M.D.1
Tyce, G.M.2
-
2
-
-
0030799456
-
Short-and long-duration responses to levodopa during the first year of levodopa therapy
-
Nutt JG, Carter JH, Van Houten L, Woodward WR. Short-and long-duration responses to levodopa during the first year of levodopa therapy. Ann Neurol 1997;42:349-355.
-
(1997)
Ann Neurol
, vol.42
, pp. 349-355
-
-
Nutt, J.G.1
Carter, J.H.2
Van Houten, L.3
Woodward, W.R.4
-
3
-
-
77951745860
-
Dopaminedependent motor learning: Insight into levodopa's longduration response
-
Beeler JA, Cao ZF, Kheirbek MA, et al. Dopaminedependent motor learning: Insight into levodopa's longduration response. Ann Neurol 2010;67:639-647.
-
(2010)
Ann Neurol
, vol.67
, pp. 639-647
-
-
Beeler, J.A.1
Cao, Z.F.2
Kheirbek, M.A.3
-
4
-
-
19744378296
-
Levodopa and the progression of Parkinson's disease
-
Fahn S, Oakes D, Shoulson I, et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004; 351:2498-2508.
-
(2004)
N Engl J Med
, vol.351
, pp. 2498-2508
-
-
Fahn, S.1
Oakes, D.2
Shoulson, I.3
-
5
-
-
0033546661
-
Pharmacodynamics of the long-duration response to levodopa in PD
-
Zappia M, Bosco D, Plastino M, et al. Pharmacodynamics of the long-duration response to levodopa in PD. Neurology 1999;53:557-560. (Pubitemid 29382051)
-
(1999)
Neurology
, vol.53
, Issue.3
, pp. 557-560
-
-
Zappia, M.1
Bosco, D.2
Plastino, M.3
Nicoletti, G.4
Branca, D.5
Oliveri, R.L.6
Aguglia, U.7
Gambardella, A.8
Quattrone, A.9
-
6
-
-
0036264465
-
Evolution of the response to levodopa during the first 4 years of therapy
-
DOI 10.1002/ana.10189
-
Nutt JG, Carter JH, Lea ES, Sexton GJ. Evolution of the response to levodopa during the first 4 years of therapy. Ann Neurol 2002;51:686-693. (Pubitemid 34568846)
-
(2002)
Annals of Neurology
, vol.51
, Issue.6
, pp. 686-693
-
-
Nutt, J.G.1
Carter, J.H.2
Lea, E.S.3
Sexton, G.J.4
-
7
-
-
70349456475
-
A double-blind, delayed-start trial of rasagiline in Parkinson's disease
-
Olanow CW, Rascol O, Hauser R, et al. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med 2009;361:1268-1278.
-
(2009)
N Engl J Med
, vol.361
, pp. 1268-1278
-
-
Olanow, C.W.1
Rascol, O.2
Hauser, R.3
-
8
-
-
0037384803
-
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
-
DOI 10.1016/S0166-2236(03)00038-9
-
Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in Parkinson's disease is not dopaminemediated. Trends Neurosci 2003;26:215-221. (Pubitemid 36412004)
-
(2003)
Trends in Neurosciences
, vol.26
, Issue.4
, pp. 215-221
-
-
Bezard, E.1
Gross, C.E.2
Brotchie, J.M.3
-
9
-
-
49449109652
-
Dichotomous dopaminergic control of striatal synaptic plasticity
-
Shen W, Flajolet M, Greengard P, Surmeier DJ. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008;321:848-851.
-
(2008)
Science
, vol.321
, pp. 848-851
-
-
Shen, W.1
Flajolet, M.2
Greengard, P.3
Surmeier, D.J.4
-
10
-
-
61349162306
-
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory
-
Di Filippo M, Picconi B, Tantucci M, et al. Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. Behav Brain Res 2009; 199:108-118.
-
(2009)
Behav Brain Res
, vol.199
, pp. 108-118
-
-
Di Filippo, M.1
Picconi, B.2
Tantucci, M.3
|